Bausch Health Companies BHC Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Bausch + Lomb | $1.24B+9.4% | $1.41B+9.8% | $1.28B+7.1% | $1.28B+5.1% | $1.14B+3.5% | |
| Diversified | $185M-9.8% | $255M+11.8% | $258M-4.1% | $219M-12.7% | $205M+1.5% | |
| International | $285M+8.8% | $306M+9.7% | $286M-1.7% | $278M+0.7% | $262M-1.1% | |
| Salix | $639M+17.9% | $693M+9.3% | $716M+11.5% | $627M+12.4% | $542M+8.6% | |
| Solta Medical | $171M+51.3% | $137M-0.7% | $140M+25.0% | $128M+25.5% | $113M+28.4% | |
| Revenue by Product | ||||||
| Other revenues | $24M-25.0% | $28M-9.7% | $24M-14.3% | $26M+8.3% | $32M+33.3% | |
| Price Appreciation Credit | $2M0.0% | $15M-16.7% | $1M— | $0— | $2M— | |
| Product sales | $2.5B+12.3% | $2.77B+9.5% | $2.66B+7.1% | $2.5B+5.3% | $2.23B+4.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bausch Health Companies break its business down?
- Bausch Health Companies (BHC) reports revenue by business across 5 parts — Bausch + Lomb, Diversified, International, Salix and Solta Medical. Each is extracted from the segment footnotes and tracked over time.
- Where does Bausch Health Companies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bausch Health Companies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
